Ajooni Biotech (AJOONI) | Financial Analysis & Statements

Ajooni Biotech Ltd. | Small-cap | Consumer Defensive

₹5.78

-0.52%

| Ajooni Biotech Stock Comparison:

No comparison data available

Overview Income Statement Balance Sheet Cash Flow Key Ratios

Financial Overview

Latest Annual: 2025

Income Metrics

Revenue 1.1B

Gross Profit 176.6M 15.40%

Operating Income 25.9M 2.26%

Net Income 33.7M 2.94%

Balance Sheet Metrics

Total Assets 950.5M

Total Liabilities 69.7M

Shareholders Equity 880.8M

Debt to Equity 0.08

Cash Flow Metrics

Operating Cash Flow -198.6M

Free Cash Flow -197.7M

Revenue & Profitability Trend

Interactive Financial Charts Not Available

This page uses interactive financial charts and dynamic data visualization tools that require JavaScript. For detailed financial analysis:

Available Financial Data:

Income statements (annual and quarterly)
Balance sheets with asset and liability details
Cash flow statements and free cash flow analysis
Key financial ratios and performance metrics
Peer comparison and industry benchmarking

All financial data is displayed in accessible table format below. Use the table headers and structure to analyze trends and compare metrics across different periods.

Ajooni Biotech Income Statement From 2021 to 2025

Metric	2025	2024	2023	2022	2021
Revenue	1.1B	801.1M	744.9M	740.4M	510.4M
Cost of Goods Sold	970.3M	703.5M	657.4M	640.1M	430.1M
Gross Profit	176.6M	97.6M	87.4M	100.2M	80.3M
Operating Expenses	112.2M	51.4M	36.3M	48.3M	48.6M
Operating Income	25.9M	15.1M	17.6M	22.2M	12.1M
Pre-tax Income	43.3M	30.0M	15.8M	14.6M	5.0M
Income Tax	9.6M	8.3M	4.5M	4.1M	1.3M
Net Income	33.7M	21.6M	11.2M	10.5M	3.7M
EPS (Diluted)	-	-	₹1.51	₹0.16	₹0.06

Income Statement Trend

Ajooni Biotech Balance Sheet From 2021 to 2025

Metric	2025	2024	2023	2022	2021
Assets
Current Assets	620.0M	323.3M	346.7M	219.3M	214.3M
Non-Current Assets	330.5M	151.9M	240.6M	70.9M	66.0M
Total Assets	950.5M	475.2M	587.3M	290.2M	280.3M
Liabilities
Current Liabilities	48.2M	30.1M	152.1M	100.6M	104.8M
Non-Current Liabilities	21.5M	18.0M	18.5M	25.8M	19.3M
Total Liabilities	69.7M	48.1M	170.6M	126.4M	124.1M
Equity
Total Shareholders Equity	880.8M	427.1M	416.7M	163.8M	156.2M

Balance Sheet Composition

Ajooni Biotech Cash Flow Statement From 2021 to 2025

Metric	2025	2024	2023	2022	2021
Operating Activities
Net Income	43.3M	30.0M	15.8M	14.6M	5.0M
Operating Cash Flow	-198.6M	42.4M	-95.5M	14.6M	-27.4M
Investing Activities
Capital Expenditures	-10.8M	-55.7M	-28.6M	991.0K	-35.3M
Investing Cash Flow	-180.2M	71.4M	-160.3M	2.3M	-34.1M
Financing Activities
Dividends Paid	-	-	-	-	-
Financing Cash Flow	249.0M	-29.4M	377.5M	-21.1M	23.9M
Free Cash Flow	-197.7M	-95.5M	-84.4M	15.6M	-23.7M

Cash Flow Trend

Ajooni Biotech Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 25.41

Price to Book 1.17

Price to Sales 0.53

Profitability Ratios

Profit Margin 2.61%

Operating Margin 2.03%

Return on Equity 4.27%

Return on Assets 3.16%

Financial Health

Current Ratio 18.13

Debt to Equity 2.36

Beta 1.23

Per Share Data

EPS (TTM) ₹0.22

Book Value per Share ₹4.78

Revenue per Share ₹4.97

Financial data is updated regularly. All figures are in the company's reporting currency.